Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cyclophosphamide 1g powder for solution for injection vials
0801010H0AAADAD
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 200mg inj vials
0801010H0AAABAB
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 25mg tablets
0801010H0AAAKAK
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 25mg/5ml oral liquid
0801010H0AAAPAP
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 35mg/5ml oral liquid
0801010H0AAAMAM
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 40mg/5ml oral liquid
0801010H0AAAVAV
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 500mg inj vials
0801010H0AAACAC
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 50mg/5ml oral liquid
0801010H0AAANAN
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 75mg/5ml oral liquid
0801010H0AAAQAQ
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyproterone 100mg/5ml oral liquid
0803042E0AAADAD
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyproterone 150mg/5ml oral liquid
0803042E0AAAHAH
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyproterone 25mg/5ml oral liquid
0803042E0AAAEAE
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyproterone 2mg/5ml oral suspension
0803042E0AAAIAI
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyproterone 50mg/5ml oral suspension
0803042E0AAAFAF
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Cyramza 100mg/10ml concentrate for inf vials
0801050BZBBAAAA
|
Cyramza | Ramucirumab | Malignant Disease and Immunosuppression | No data available |
|
Cyramza 500mg/50ml concentrate for inf vials
0801050BZBBABAB
|
Cyramza | Ramucirumab | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine (liposomal) 50mg/5ml inj vials
0801030D0AAANAN
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 100mg/1ml solution for injection vials
0801030D0AAAHAH
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 100mg/5ml solution for injection Cytosafe vials
0801030D0BFAAAI
|
Cytarabine (Cytosafe) | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 100mg/5ml solution for injection vials
0801030D0AAAIAI
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 1g/10ml solution for injection Cytosafe vials
0801030D0BFACAK
|
Cytarabine (Cytosafe) | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 1g/10ml solution for injection vials
0801030D0AAAKAK
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 2g/20ml solution for injection Cytosafe vials
0801030D0BFADAL
|
Cytarabine (Cytosafe) | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 2g/20ml solution for injection vials
0801030D0AAALAL
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
|
Cytarabine 4g/40ml solution for injection vials
0801030D0AAAPAP
|
Cytarabine | Cytarabine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.